A formerly unidentified hereditary transformation in a little protein gives critical security against Parkinson's illness and offers another course for investigating expected medicines, as per another USC Leonard Davis School of Gerontology review. The variation, situated in a mitochondrial microprotein named SHLP2, was viewed as profoundly defensive against Parkinson's illness; people with this change are half as prone to fostering the sickness as the individuals who don't convey it. The variation type of the protein is generally uncommon and is tracked down principally in individuals of European plummet. The discoveries show up in the journal Atomic Psychiatry. First found by